Spark to charge $850,000 per patient for blindness gene therapy

(Reuters) - Spark Therapeutics Inc said on Wednesday it will charge $850,000 per patient for its breakthrough gene therapy to treat a rare form of blindness, a lower than expected price that the company said reflects patient and insurer concerns about access and cost.

Source: Reuters: Health - January 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news